![Gudarz Davar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gudarz Davar worked as the VP & Head-Global Neurology Clinical Development at Eli Lilly & Co. from 2017 to 2020.
Prior to that, he was the Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc. Dr. Davar holds a doctorate degree from Dalhousie University.
Tidigare kända positioner av Gudarz Davar
| Företag | Position | Slut |
|---|---|---|
| ELI LILLY AND COMPANY | Företagsledare/Principal | 2020-08-01 |
| ACADIA PHARMACEUTICALS INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Gudarz Davars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
58
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
